On Demand
1hr 59 min
Share webinar

Comprehensive genomic profiling is essential for precision oncology. The speakers evaluated cancer gene panels on MGI's G400 and G99 DNBSEQ systems. Agilent's assay offers tumor profiling on G400; GenePLUS has a 1021-gene panel; NGeneBio targets 18-343 genes for various cancers. These systems achieve >90% Q30, >50X coverage, detecting variants down to 1% allele frequency. MGI's systems offer speed, scalability, and cost-effectiveness, supporting both large and targeted panels for cancer research and diagnostics, advancing genomic medicine.

Dr. William Tan Associate Director @MiRXES

Dr. Michael Ruvolo Director, R&D @Agilent Technologies

Dr. Xiaorui Han Overseas Product Manager @Geneplus

Dr. Felicity Hall Senior Global Product Manager @Agilent Technologies

Dr. Kathy K.S. Lee Team leader @NGeneBio

Spatial Transcriptomics with Stereo-seq Reveals the Hidden Tumor Microbiome
Spatial Transcriptomics with Stereo-seq Reveals the Hidden Tumor Microbiome
Spatial Transcriptomics with Stereo-seq Reveals the Hidden Tumor Microbiome

Advances in Preimplantation Genetic Diagnosis: Reproductive Solutions Powered by NGS (ENG)
Advances in Preimplantation Genetic Diagnosis: Reproductive Solutions Powered by NGS (ENG)
Advances in Preimplantation Genetic Diagnosis: Reproductive Solutions Powered by NGS (ENG)

Avances en el Diagnóstico Genético Preimplantacional: Soluciones Reproductivas Impulsadas por NGS
Avances en el Diagnóstico Genético Preimplantacional: Soluciones Reproductivas Impulsadas por NGS
Avances en el Diagnóstico Genético Preimplantacional: Soluciones Reproductivas Impulsadas por NGS

Decode Half Million Genomes in Half Year
Decode Half Million Genomes in Half Year
Decode Half Million Genomes in Half Year

The Clinical Utility of Multigene Panel Analysis in Precision Oncology
The Clinical Utility of Multigene Panel Analysis in Precision Oncology
The Clinical Utility of Multigene Panel Analysis in Precision Oncology

Building a National Genomic Infrastructure as Part of the European 1+ Million Genomes Initiative:
Building a National Genomic Infrastructure as Part of the European 1+ Million Genomes Initiative:
Building a National Genomic Infrastructure as Part of the European 1+ Million Genomes Initiative:

Single-cell profiling of the human endometrium in polycystic ovary syndrome
Single-cell profiling of the human endometrium in polycystic ovary syndrome
Single-cell profiling of the human endometrium in polycystic ovary syndrome

Unlocking precision Oncology: How OncoDNA and MGI provide accessible CPG for cancer patients
Unlocking precision Oncology: How OncoDNA and MGI provide accessible CPG for cancer patients
Unlocking precision Oncology: How OncoDNA and MGI provide accessible CPG for cancer patients

An Oasis in the Desert: Mapping the Immunogenic Effects of Novel Treatment Strategies in Pancreatic Cancer with Stereo-seq OMNI.
An Oasis in the Desert: Mapping the Immunogenic Effects of Novel Treatment Strategies in Pancreatic Cancer with Stereo-seq OMNI.
An Oasis in the Desert: Mapping the Immunogenic Effects of Novel Treatment Strategies in Pancreatic Cancer with Stereo-seq OMNI.

Harnessing Ai for Precision Medicine
Harnessing Ai for Precision Medicine
Harnessing Ai for Precision Medicine

Making The Implementation of Monogenic Hereditary Diseases Diagnosis Easy
Making The Implementation of Monogenic Hereditary Diseases Diagnosis Easy
Making The Implementation of Monogenic Hereditary Diseases Diagnosis Easy

Integrating RNA-seq and Tumor Microenvironment (TME)
Integrating RNA-seq and Tumor Microenvironment (TME)
Integrating RNA-seq and Tumor Microenvironment (TME)

Population-based surveillance for inherited disorders
Population-based surveillance for inherited disorders
Population-based surveillance for inherited disorders

The Advantage Of Using DNBSEQ Technology
The Advantage Of Using DNBSEQ Technology
The Advantage Of Using DNBSEQ Technology

Transforming Clinical Diagnostics
Transforming Clinical Diagnostics
Transforming Clinical Diagnostics

Closing the Cancer Care Gap with the Power of Precision Oncology
Closing the Cancer Care Gap with the Power of Precision Oncology
Closing the Cancer Care Gap with the Power of Precision Oncology
Building the Largest Database of Human Microbiomes
Building the Largest Database of Human Microbiomes
Building the Largest Database of Human Microbiomes
Immune Repertoire Profiling with DNBSEQ
Immune Repertoire Profiling with DNBSEQ
Immune Repertoire Profiling with DNBSEQ

Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy
Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy
Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy

SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics
SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics
SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics
Revolutionizing Agriculture, Harnessing The Power of Genomics
Revolutionizing Agriculture, Harnessing The Power of Genomics
Revolutionizing Agriculture, Harnessing The Power of Genomics
Whole Exome Sequencing with DNBSEQ
Whole Exome Sequencing with DNBSEQ
Whole Exome Sequencing with DNBSEQ
Clinical Exome Sequencing to reporting
Clinical Exome Sequencing to reporting
Clinical Exome Sequencing to reporting

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.